CONGENITAL CYTOMEGALOVIRAL (CMV) DISEASE

Clinical trials for CONGENITAL CYTOMEGALOVIRAL (CMV) DISEASE explained in plain language.

Never miss a new study

Get alerted when new CONGENITAL CYTOMEGALOVIRAL (CMV) DISEASE trials appear

Sign up with your email to follow new studies for CONGENITAL CYTOMEGALOVIRAL (CMV) DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Mother's immune cells could help fight severe CMV in newborns

Disease control Recruiting now

This study tests whether adding special immune cells from the mother to standard antiviral medicine can safely and more effectively treat moderate to severe CMV infection in newborns. Babies up to 21 days old with confirmed CMV disease may join. All receive antiviral drugs, and s…

Matched conditions: CONGENITAL CYTOMEGALOVIRAL (CMV) DISEASE

Phase: PHASE2 • Sponsor: New York Medical College • Aim: Disease control

Last updated Jun 27, 2026 12:02 UTC

CONGENITAL CYTOMEGALOVIRAL (CMV) DISEASE

Get alerted when new CONGENITAL CYTOMEGALOVIRAL (CMV) DISEASE trials appear

Mother's immune cells could help fight severe CMV in newborns